- Home
- AIRT vs RFL Comparison
AIRT vs RFL Comparison
Compare AIRT & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- RFL
- Stock Information
- Founded
- AIRT 1980
- RFL 2017
- Country
- AIRT United States
- RFL United States
- Employees
- AIRT N/A
- RFL N/A
- Industry
- AIRT Air Freight/Delivery Services
- RFL Real Estate
- Sector
- AIRT Consumer Discretionary
- RFL Finance
- Exchange
- AIRT Nasdaq
- RFL Nasdaq
- Market Cap
- AIRT 59.6M
- RFL 54.4M
- IPO Year
- AIRT N/A
- RFL N/A
- Fundamental
- Price
- AIRT $24.46
- RFL $1.41
- Analyst Decision
- AIRT
- RFL
- Analyst Count
- AIRT 0
- RFL 0
- Target Price
- AIRT N/A
- RFL N/A
- AVG Volume (30 Days)
- AIRT 1.2K
- RFL 122.7K
- Earning Date
- AIRT 11-11-2025
- RFL 11-05-2025
- Dividend Yield
- AIRT N/A
- RFL N/A
- EPS Growth
- AIRT N/A
- RFL N/A
- EPS
- AIRT N/A
- RFL N/A
- Revenue
- AIRT $296,309,000.00
- RFL $732,000.00
- Revenue This Year
- AIRT N/A
- RFL N/A
- Revenue Next Year
- AIRT N/A
- RFL N/A
- P/E Ratio
- AIRT N/A
- RFL N/A
- Revenue Growth
- AIRT 5.14
- RFL 35.56
- 52 Week Low
- AIRT $14.56
- RFL $1.28
- 52 Week High
- AIRT $26.70
- RFL $3.19
- Technical
- Relative Strength Index (RSI)
- AIRT 55.22
- RFL 44.41
- Support Level
- AIRT $22.63
- RFL $1.31
- Resistance Level
- AIRT $26.37
- RFL $1.48
- Average True Range (ATR)
- AIRT 0.33
- RFL 0.12
- MACD
- AIRT 0.12
- RFL 0.01
- Stochastic Oscillator
- AIRT 53.53
- RFL 40.74
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.